Kathryn Guarini's most recent trade in Regeneron Pharmaceuticals, Inc. was a trade of 1,958 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Regeneron Pharma | Kathryn Guarini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,958 | 1,958 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Kathryn Guarini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 166 | 448 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Kathryn Guarini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 508 | 508 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Kathryn Guarini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 42 | 282 (0%) | 0% | 0 | Common Stock |